We are live on ! Find out more
BM

Brandywine Managers Portfolio holdings

AUM $202M
1-Year Est. Return 16.99%
This Fund
S&P 500
This Quarter Est. Return
+23.04%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$101M
AUM Growth
+$17.3M
Cap. Flow
+$6.72K
Cap. Flow %
0.01%
Top 10 Hldgs %
84.01%
Holding
36
New
1
Increased
3
Reduced
8
Closed
–

Top Buys

Rank Stock Value
1
VKTX icon
Viking Therapeutics
VKTX
+$213K
2
KVYO icon
Klaviyo
KVYO
+$138K
3
BEAM icon
Beam Therapeutics
BEAM
+$127K
4
MDB icon
MongoDB
MDB
+$115K

Top Sells

Rank Stock Value
1
S icon
SentinelOne
S
+$155K
2
VEEV icon
Veeva Systems
VEEV
+$124K
3
AMD icon
Advanced Micro Devices
AMD
+$87.1K
4
OKTA icon
Okta
OKTA
+$85.4K
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$36K

Sector Composition

Rank Sector Weight
1 Technology 50.63%
2 Miscellaneous 37.53%
3 Healthcare 10.84%
4 Financials 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDGR icon
26
Schrodinger
SDGR
$1.5B
$420K 0.42%
20,886
– –
BEAM icon
27
Beam Therapeutics
BEAM
$3.06B
$316K 0.31%
18,606
+7,300
+65% +$127K
TWLO icon
28
Twilio
TWLO
$35.8B
$293K 0.29%
2,357
– –
MRNA icon
29
Moderna
MRNA
$58.1B
$262K 0.26%
9,510
– –
NVO
30
Novo Nordisk
NVO
$206B
$259K 0.26%
3,747
-475
-11% -$32.3K
GPCR icon
31
Structure Therapeutics
GPCR
$3.38B
$229K 0.23%
11,057
– –
TXG icon
32
10x Genomics
TXG
$8.16B
$219K 0.22%
18,938
– –
VKTX icon
33
Viking Therapeutics
VKTX
$4.07B
$214K 0.21%
+8,082
New +$213K
S icon
34
SentinelOne
S
$6.92B
$192K 0.19%
10,501
-8,500
-45% -$155K
RLAY icon
35
Relay Therapeutics
RLAY
$4.17B
$133K 0.13%
38,429
– –
ABCL icon
36
AbCellera Biologics
ABCL
$3.7B
$97.7K 0.1%
28,488
– –
1
2

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
WPW
Winthrop Partners - WNY Buffalo, New York $202M AUM
HWA
Hilltop Wealth Advisors Chapel Hill, North Carolina $202M AUM 24.55% 1-Year Est. Return
DFG
Delphi Financial Group Wilmington, Delaware $202M AUM 21.25% 1-Year Est. Return
LAMC
Longview Asset Management (California) San Rafael, California $202M AUM 11.36% 1-Year Est. Return
FC
Farringdon Capital London, United Kingdom $202M AUM 4.1% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $203M AUM 60.82% 1-Year Est. Return
MRCM
Mill Road Capital Management Greenwich, Connecticut $203M AUM 79.43% 1-Year Est. Return

Brandywine Managers's Q2 2025 Portfolio in Review

As of Q2 2025, Brandywine Managers held 36 positions worth $101M, up 21% from $83.4M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 2.8%. Brandywine Managers opened 1 new position and made no exits, leaving the 36-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Brandywine Managers's largest Q2 2025 buy was Viking Therapeutics: 8,082 shares worth $214K.
  • Brandywine Managers added most to Klaviyo in Q2 2025, an estimated $138K increase.
  • Brandywine Managers's biggest Q2 2025 reduction was SentinelOne, cutting an estimated $155K.
  • Brandywine Managers's ten largest holdings make up 84% of its $101M portfolio in Q2 2025.
  • Brandywine Managers opened 1 new position and closed 0 in Q2 2025.
  • Brandywine Managers's portfolio value rose 21% quarter-over-quarter to $101M.

Based on Brandywine Managers's 13F filing for Q2 2025, filed 14 Aug 2025.